Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;5(6):1176-1183.
doi: 10.1002/ehf2.12354. Epub 2018 Sep 19.

Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure

Affiliations

Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure

Werner Mohl et al. ESC Heart Fail. 2018 Dec.

Abstract

Aims: Cardiac repair has steered clinical attention and remains an unmet need, because available regenerative therapies lack robust mechanistic evidence. Pressure-controlled intermittent coronary sinus occlusion (PICSO), known to induce angiogenetic and vasoactive molecules as well as to reduce regional ischemia, may activate endogenous regenerative processes in failing myocardium. We aimed to investigate the effects of PICSO in patients with advanced heart failure undergoing cardiac resynchronization therapy.

Methods and results: Eight out of 32 patients were treated with PICSO, and the remainder served as controls. After electrode testing including left ventricular leads, PICSO was performed for 20 min. To test immediate molecular responses, in both patient groups, coronary venous blood samples were taken at baseline and after 20 min, the time required for the intervention. Sera were tested for microRNAs and growth factors. To test the ability of up-regulated soluble factors on cell proliferation and expression of transcription factors [e.g. Krüppel-like factor 4 (KLF-4)], sera were co-cultured with human cardiomyocytes and fibroblasts. As compared with controls, significant differential expression (differences between pre-values and post-values in relation to both patient cohorts) of microRNA patterns associated with cardiac development was observed with PICSO. Importantly, miR-143 (P < 0.048) and miR-145 (P < 0,047) increased, both targeting a network of transcription factors (including KLF-4) that promote differentiation and repress proliferation of vascular smooth muscle cells. Additionally, an increase of miR-19b (P < 0.019) known to alleviate endothelial cell apoptosis was found, whereas disadvantageous miR-320b (P < 0.023) suspect to impair expression of c-myc, normally provoking cell cycle re-entry in post-mitotic myocytes and miR-25 (P < 0.023), decreased, a target of anti-miR application to improve contractility in the failing heart. Co-cultured post-PICSO sera significantly increased cellular proliferation both in fibroblasts (P < 0.001) and adult cardiomycytes (P < 0.004) sampled from a transplant recipient as compared with controls. Adult cardiomyocytes showed a seven-fold increase of the transcription factor KLF-4 protein when co-cultured with treated sera as compared with controls.

Conclusions: Here, we show for the first time that PICSO, a trans-coronary sinus catheter intervention, is associated with an increase in morphogens secreted into cardiac veins, normally present during cardiac development, and a significant induction of cell proliferation. Present findings support the notion that epigenetic modifications, that is, haemodynamic stimuli on venous vascular cells, may reverse myocardial deterioration. Further investigations are needed to decipher the maze of complex interacting molecular pathways in failing myocardium and the potential role of PICSO to reinitiate developmental processes to prevent further myocardial decay eventually reaching clinical significance.

Keywords: Cardiac regeneration; Embryonic recall; Heart failure; PICSO.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study protocol and serum collection. (A) After advancement of a coronary sinus catheter and temporary pressure‐controlled occlusion (PICSO) of a major portion of outflow from coronary veins, pressures are increased as seen in (B); systolic pressures peaks are thought to be the driving force to activate venous endothelium. (C) Immediately frozen to −80°, (D) human fibroblasts and cardiomyocytes are co‐cultured with patient sera to estimate the proliferative power of each serum. After primary culture, cells underwent a starving period before co‐cultured with patient serum.
Figure 2
Figure 2
Differentially expressed microRNA (miRNA). Here, we show differentially expressed miRNA for both groups. Delta differences between first and second serum collection are shown as mean ddCP for both groups. After normalization of data to global mean, a delta Cq value is obtained (dCq). Differences in expression levels are calculated as dCq (1) − dCq (2) = ddCq. Only statistically significant patterns of miRNA expression are shown. miRNA 145 is involved in a double negative feedback loop with Krüppel‐like factor 4 inducing lineage restricted differentiation. PICSO, pressure‐controlled intermittent coronary sinus occlusion.
Figure 3
Figure 3
Krüppel‐like factor 4 (KLF‐4) in cardiomyocytes after serum exposure. Cardiomyocytes supravitally sampled from transplant recipient hearts were exposed to serum collected in three control and three pressure‐controlled intermittent coronary sinus occlusion (PICSO) patients according to protocol. Pre‐control and post‐control were set as baseline fluorescence intensity to compare signal differences in PICSO patients. Blue bar, 30 min; red bar, 60 min; orange, 120 min after treatment start. Groups are indicated on the bottom. Bars indicate fold change to control group as defined as 1. Mean fold change is given above error bars of standard deviation. Signalling of sera co‐cultured seem to peak at 60 min and decline thereafter.
Figure 4
Figure 4
Real‐time cell index for (A) human primary cardiomyocytes sampled from an explanted heart from a patient with heart failure during transplantation and (B) commercially available fibroblasts cultured in the presence of PICSO (n = 5 patients) or non‐PICSO (n = 6 patients) sera from pre‐procedure and post‐procedure. Cells index was measured up to 250 and 144 h for fibroblast and primary cardiomyocytes, respectively. Student's t‐test significance is given in the graphs on the right for comparisons among groups at the end of the measurement periods. Note that post‐PICSO sera induced additional proliferation, whereas in post‐control sera, no change was evident.

Similar articles

Cited by

References

    1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123–1133. - PubMed
    1. Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisen J, Giacca M, Hare JM, Houser S, Lee RT, Marbán E, Martin JF, Molkentin JD, Murry CE, Riley PR, Ruiz‐Lozano P, Sadek HA, Sussman MA, Hill JA. Cardiomyocyte regeneration: a consensus statement. Circulation 2017; 136: 680–686. - PMC - PubMed
    1. Mohl W, Gangl C, Jusić A, Aschacher T, De Jonge M, Rattay F. PICSO: from myocardial salvage to tissue regeneration. Cardiovasc Revasc Med 2015; 16: 36–46. - PubMed
    1. Pappalardo F, Ancona MB, Giannini F, Regazzoli D, Mangieri A, Montorfano M, de Bonis M, Alfieri O, Zangrillo A, Scandroglio AM, Colombo A, Latib A. First in man prolonged pressure‐controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischaemia with patent epicardial coronary arteries. Int J Cardiol 2017; 241: 138–141. - PubMed
    1. Yan S, Jiao K. Functions of miRNAs during mammalian heart development. Int J Mol Sci 2016; 17: 789 - PMC - PubMed

Publication types